+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Kaempferol 3-O-(2""-O-α-rhamnosyl-6""-O-malonyl)-β-glucoside

BP4829
528606-92-0
98%
Phytopurify
1. Kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome. 2. Kaempferol exerts a potent inhibitory effect on in vitro bone resorption. 3. Kaempferol has anti-inflammatory action, can prevent and treat inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis. 4. Kaempferol has therapeutic potential for the prevention and treatment of thrombovascular diseases, can enhance relaxations caused by endothelium-derived and exogenous NO as well as those due to endothelium-dependent hyperpolarization. 5. Kaempferol can inhibit cancer cell invasion through blocking the PKCδ/MAPK/AP-1 cascade and subsequent MMP-9 expression and its activity, may act as a therapeutic potential candidate for cancer metastasis. 6. Kaempferol is an autophagic enhancer, has a more general protection in Parkinson's disease, can mediate antiapoptotic and antioxidant effects is the enhancement of mitochondrial turnover by autophagy.
Catalog No Package Original Price Price Inventory Quantity Operating
BP4829-5mg 5mg
BP4829-10mg 10mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

PRKCD RELA MAPK1 JUN MMP9 CDH1
NOS3 P2RY12 PRKG1 KCNMA1

Product drug property prediction parameters

  • 292.5700

  • -.2720

  • -2.3461

  • 3.6661

  • .3878

  • .1078

  • Low

  • 79.0951

  • 4.8812

  • Yes

  • No

  • Yes

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • Yes

  • Yes

  • No